ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $133,204 | +788.0% | 6,164 | +705.8% | 0.00% | – |
| Q3 2022 | $15,000 | +87.5% | 765 | +88.4% | 0.00% | – |
| Q2 2022 | $8,000 | -99.4% | 406 | -99.0% | 0.00% | – |
| Q1 2022 | $1,232,000 | +241.3% | 41,298 | +166.4% | 0.00% | – |
| Q4 2021 | $361,000 | +1800.0% | 15,502 | +2400.3% | 0.00% | – |
| Q3 2021 | $19,000 | -9.5% | 620 | +3.3% | 0.00% | – |
| Q2 2021 | $21,000 | -97.9% | 600 | -97.9% | 0.00% | – |
| Q1 2021 | $987,000 | +32800.0% | 28,001 | +31012.2% | 0.00% | – |
| Q4 2020 | $3,000 | -98.3% | 90 | -98.3% | 0.00% | – |
| Q3 2020 | $177,000 | +56.6% | 5,304 | +24.2% | 0.00% | – |
| Q2 2020 | $113,000 | -6.6% | 4,272 | -42.0% | 0.00% | – |
| Q1 2020 | $121,000 | -71.0% | 7,365 | -55.1% | 0.00% | – |
| Q4 2019 | $417,000 | +109.5% | 16,407 | +64.7% | 0.00% | – |
| Q3 2019 | $199,000 | +114.0% | 9,962 | +247.2% | 0.00% | – |
| Q2 2019 | $93,000 | +9200.0% | 2,869 | +11376.0% | 0.00% | – |
| Q1 2019 | $1,000 | -98.8% | 25 | -99.3% | 0.00% | – |
| Q4 2018 | $82,000 | -82.8% | 3,354 | -76.9% | 0.00% | – |
| Q3 2018 | $478,000 | +20.1% | 14,505 | +29.3% | 0.00% | – |
| Q2 2018 | $398,000 | +33.6% | 11,218 | +22.7% | 0.00% | – |
| Q1 2018 | $298,000 | +27.4% | 9,141 | 0.0% | 0.00% | – |
| Q4 2017 | $234,000 | – | 9,141 | +914000.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 1 | -99.6% | 0.00% | – |
| Q1 2017 | $6,000 | – | 245 | +24400.0% | 0.00% | – |
| Q4 2016 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |